Legac E - Search Results

1

Expression of V beta gene segments by Sezary cells.

Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L, Sigaux F. Gorochov G, et al. Among authors: legac e. J Invest Dermatol. 1995 Jul;105(1):56-61. doi: 10.1111/1523-1747.ep12312560. J Invest Dermatol. 1995. PMID: 7542297 Free article.

2

CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection.

Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. Legac E, et al. Blood. 1992 Apr 1;79(7):1746-53. Blood. 1992. PMID: 1373086 Free article.

3

A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients.

Autran B, Legac E, Blanc C, Debré P. Autran B, et al. Among authors: legac e. J Immunol. 1995 Feb 1;154(3):1408-17. J Immunol. 1995. PMID: 7529803

4

[Amplification of a circulating CD4+CD7- T lymphocytes subset in kidney transplantation].

Barrou B, Legac E, Bitker MO, Jacobs C, Chatelain C, Debré P, Autran B. Barrou B, et al. Among authors: legac e. Presse Med. 1992 Dec 2;21(41):1989-90. Presse Med. 1992. PMID: 1284174 French.

5

Expansion of CD4+CD7- T helper cells with a TH0-TH2 function in kidney transplant recipients.

Barrou B, Legac E, Blanc C, Bitker MO, Luciani J, Chatelain C, Debré P, Autran B. Barrou B, et al. Among authors: legac e. Transplant Proc. 1995 Apr;27(2):1676-7. Transplant Proc. 1995. PMID: 7536977 No abstract available.

6

T lymphocyte subsets in primary antiphospholipid syndrome.

Papo T, Piette JC, Legac E, Frances C, Grenot P, Debre P, Godeau P, Autran B. Papo T, et al. Among authors: legac e. J Rheumatol. 1994 Dec;21(12):2242-5. J Rheumatol. 1994. PMID: 7699624

7

Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx.

Michel F, Merle-Béral H, Legac E, Michel A, Debré P, Bismuth G. Michel F, et al. Among authors: legac e. J Immunol. 1993 Apr 15;150(8 Pt 1):3624-33. J Immunol. 1993. PMID: 8096854

8

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia.

Letestu R, Dahmani A, Boubaya M, Baseggio L, Campos L, Chatelain B, Debliquis A, Drénou B, Jacob MC, Legac E, Le Garff-Tavernier M, Lhoumeau AC, Quiney C, Robillard N, Ticchioni M, Aanei C, Katsahian S, Delepine R, Vaudaux S, Rouillé V, Béné MC, Dartigeas C, Van Den Neste E, Leprêtre S, Feugier P, Cartron G, Leblond V, Lévy V, Cymbalista F; French Innovative Leukemia Organization (FILO). Letestu R, et al. Among authors: legac e. Leukemia. 2021 Jun;35(6):1597-1609. doi: 10.1038/s41375-020-01009-z. Epub 2020 Sep 15. Leukemia. 2021. PMID: 32934355

9

Characterization of normal human bone marrow by flow cytometry.

Blanc C, Legac E, Binet JL, Michel A, Debré P, Merle-Beral H. Blanc C, et al. Among authors: legac e. Nouv Rev Fr Hematol (1978). 1991;33(3):231-5. Nouv Rev Fr Hematol (1978). 1991. PMID: 1956760

10

Proposals for a Phenotypic Classification of B-Chronic Lymphocytic Leukemia, Relationship with Prognostic Factors.

Legac E, Chastang C, Binet JL, Michel A, Debre P, Merle-Beral H. Legac E, et al. Leuk Lymphoma. 1991;5 Suppl 1:53-8. doi: 10.3109/10428199109103379. Leuk Lymphoma. 1991. PMID: 27463480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters